Early-Onset Colorectal Cancer: Molecular Underpinnings Accelerating Occurrence.

IF 7.1 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Cellular and Molecular Gastroenterology and Hepatology Pub Date : 2024-11-05 DOI:10.1016/j.jcmgh.2024.101425
Atehkeng Zinkeng, F Lloyd Taylor, Samuel H Cheong, Heyu Song, Juanita L Merchant
{"title":"Early-Onset Colorectal Cancer: Molecular Underpinnings Accelerating Occurrence.","authors":"Atehkeng Zinkeng, F Lloyd Taylor, Samuel H Cheong, Heyu Song, Juanita L Merchant","doi":"10.1016/j.jcmgh.2024.101425","DOIUrl":null,"url":null,"abstract":"<p><p>The onset of colorectal cancer (CRC) in patients under 50 continues to rapidly increase. This study highlights the epidemiological changes, risk factors, clinical characteristics, and molecular profiles prevalent in early-onset colorectal cancer (EO-CRC) patients, and identifies key areas for future research. It has been noted that only a small fraction of EO-CRC cases is attributed to known hereditary mutations and fit the canonical pathway of late onset colorectal cancer (LOCRC) development. To highlight this, we review the genetic and epigenetic modifications specific to EO-CRC. We also discuss the synergetic effect of single nucleotide polymorphisms (SNPs) and environmental factors on the early onset of CRC. Additionally, we discuss the potential of non-invasive biomarker assays to enhance early detection, screening, diagnosis, and prognostic outcome predictions.</p>","PeriodicalId":55974,"journal":{"name":"Cellular and Molecular Gastroenterology and Hepatology","volume":" ","pages":"101425"},"PeriodicalIF":7.1000,"publicationDate":"2024-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cellular and Molecular Gastroenterology and Hepatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jcmgh.2024.101425","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

The onset of colorectal cancer (CRC) in patients under 50 continues to rapidly increase. This study highlights the epidemiological changes, risk factors, clinical characteristics, and molecular profiles prevalent in early-onset colorectal cancer (EO-CRC) patients, and identifies key areas for future research. It has been noted that only a small fraction of EO-CRC cases is attributed to known hereditary mutations and fit the canonical pathway of late onset colorectal cancer (LOCRC) development. To highlight this, we review the genetic and epigenetic modifications specific to EO-CRC. We also discuss the synergetic effect of single nucleotide polymorphisms (SNPs) and environmental factors on the early onset of CRC. Additionally, we discuss the potential of non-invasive biomarker assays to enhance early detection, screening, diagnosis, and prognostic outcome predictions.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
早发结直肠癌:加速发病的分子基础。
50 岁以下患者罹患结直肠癌(CRC)的人数持续快速增长。本研究强调了早发结直肠癌(EO-CRC)患者的流行病学变化、风险因素、临床特征和分子特征,并确定了未来研究的关键领域。人们注意到,EO-CRC 病例中只有一小部分归因于已知的遗传突变,并符合晚发结直肠癌(LOCRC)的典型发展途径。为了强调这一点,我们回顾了 EO-CRC 特有的遗传和表观遗传修饰。我们还讨论了单核苷酸多态性(SNPs)和环境因素对 CRC 早期发病的协同作用。此外,我们还讨论了非侵入性生物标志物检测在加强早期检测、筛查、诊断和预后结果预测方面的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
13.00
自引率
2.80%
发文量
246
审稿时长
42 days
期刊介绍: "Cell and Molecular Gastroenterology and Hepatology (CMGH)" is a journal dedicated to advancing the understanding of digestive biology through impactful research that spans the spectrum of normal gastrointestinal, hepatic, and pancreatic functions, as well as their pathologies. The journal's mission is to publish high-quality, hypothesis-driven studies that offer mechanistic novelty and are methodologically robust, covering a wide range of themes in gastroenterology, hepatology, and pancreatology. CMGH reports on the latest scientific advances in cell biology, immunology, physiology, microbiology, genetics, and neurobiology related to gastrointestinal, hepatobiliary, and pancreatic health and disease. The research published in CMGH is designed to address significant questions in the field, utilizing a variety of experimental approaches, including in vitro models, patient-derived tissues or cells, and animal models. This multifaceted approach enables the journal to contribute to both fundamental discoveries and their translation into clinical applications, ultimately aiming to improve patient care and treatment outcomes in digestive health.
期刊最新文献
Mouse models for pancreatic ductal adenocarcinoma are affected by the cre-driver used to promote KRASG12D activation. PKMζ, a brain-specific PKCζ isoform, is required for glycolysis and myofibroblastic activation of hepatic stellate cells. Early-Onset Colorectal Cancer: Molecular Underpinnings Accelerating Occurrence. Normalization of CF Immune System Reverses Intestinal Neutrophilic Inflammation and Significantly Improves the Survival of CF Mice. Mouse Models for Chronic Hepatitis B: Old Challenges, Novel Approaches.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1